According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is HK$0.26 Billion. In 2023 the company made a revenue of HK$0.11 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.